These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7908610)

  • 1. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
    Bristow MR; O'Connell JB; Gilbert EM; French WJ; Leatherman G; Kantrowitz NE; Orie J; Smucker ML; Marshall G; Kelly P
    Circulation; 1994 Apr; 89(4):1632-42. PubMed ID: 7908610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.
    Woodley SL; Gilbert EM; Anderson JL; O'Connell JB; Deitchman D; Yanowitz FG; Mealey PC; Volkman K; Renlund DG; Menlove R
    Circulation; 1991 Dec; 84(6):2426-41. PubMed ID: 1683602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers.
    Lindenfeld J; Robertson AD; Lowes BD; Bristow MR;
    J Am Coll Cardiol; 2001 Dec; 38(7):1950-6. PubMed ID: 11738299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
    Eichhorn EJ; Bedotto JB; Malloy CR; Hatfield BA; Deitchman D; Brown M; Willard JE; Grayburn PA
    Circulation; 1990 Aug; 82(2):473-83. PubMed ID: 1973638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).
    Eichhorn EJ; Grayburn PA; Mayer SA; St John Sutton M; Appleton C; Plehn J; Oh J; Greenberg B; DeMaria A; Frantz R; Krause-Steinrauf H
    Circulation; 2003 Nov; 108(19):2336-41. PubMed ID: 14597587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and energetic comparison of bucindolol and metoprolol for the treatment of congestive heart failure.
    Heesch CM; Marcoux L; Hatfield B; Eichhorn EJ
    Am J Cardiol; 1995 Feb; 75(5):360-4. PubMed ID: 7856528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy.
    Anderson JL; Gilbert EM; O'Connell JB; Renlund D; Yanowitz F; Murray M; Roskelley M; Mealey P; Volkman K; Deitchman D
    J Am Coll Cardiol; 1991 May; 17(6):1373-81. PubMed ID: 1673132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bucindolol in heart failure.
    Eichhorn EJ
    Am J Cardiol; 1993 Mar; 71(9):65C-70C. PubMed ID: 8096677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
    Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F
    Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
    Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D; Bergemann A; Sliwa K; Candy G; Sareli P
    Circulation; 2001 Feb; 103(8):1083-8. PubMed ID: 11222470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST.
    White M; Desai RV; Guichard JL; Mujib M; Aban IB; Ahmed MI; Feller MA; de Denus S; Ahmed A
    Can J Cardiol; 2012 May; 28(3):354-9. PubMed ID: 21982425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incomplete bucindolol evaluation in acute myocardial infarction Trial (BEAT).
    Torp-Pedersen C; Køber L; Ball S; Hall A; Brendorp B; Ottesen M; Berning J; Jensen G; Hampton J; Zilles P; Eberle S; Carlsen J
    Eur J Heart Fail; 2002 Aug; 4(4):495-9. PubMed ID: 12167390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.